ALS runs in families. But that doesn’t mean someone with no family history of the disease is protected from it. In fact, most cases do not appear to be hereditary.


That’s because ALS can be either familial or sporadic. Familial ALS is clearly genetic: There’s a family history of ALS. In contrast, sporadic ALS, which accounts for roughly 90% to 95% of ALS cases, appears to occur randomly (sporadically) in people with no known family history of ALS. 


Keep in mind that these two types of ALS are clinically indistinguishable. The symptoms and disease progression are the same. There’s only one slight difference: People with familial ALS will usually begin showing symptoms in their late 40s to early 50s. People with sporadic ALS typically become symptomatic in their late 50s to early 60s.1


ALS symptoms do vary by individual, but it’s unrelated to whether patients’ cases are sporadic or familial. It usually starts in one of two ways: as weakness in the limbs, called limb (or spinal) onset, or difficulty in speaking or swallowing, termed bulbar onset.2


Does ALS Have a Genetic Link?

Both familial and sporadic ALS can be genetic; researchers have identified more than 30 genes that have an association with ALS.


That means sporadic ALS may only appear random. Lack of a family history doesn’t rule out a genetic component. For example, in some sporadic cases, the family history may be unknown — perhaps a parent died before showing signs of the disease. Occasionally, neither parent has the mutation: It occurs for the first time in the person with ALS.3


In fact, 17% of sporadic cases may be caused by a gene mutation. C9orf72 mutations account for 25% to 40% of familial ALS cases and about 7% of sporadic cases. SOD1 mutations account for about 20% of familial ALS and 2% of sporadic ALS.4,5,6 


So clearly, genes appear to contribute to the development of sporadic ALS. However, their role remains poorly understood. Only about 10% of patients with sporadic ALS appear to carry a genetic mutation that is known to be associated with familial ALS. One theory is that many small genetic variations may interact to affect a person’s risk of developing the disease.7


What Causes Sporadic ALS?

Sporadic ALS appears to be the result of a combination of genetic and environmental factors. One hypothesis is that genetic variations can change a person’s susceptibility to ALS, even if these variations don’t actually cause the disease.8


So beyond gene mutations, what are the other potential causes? The list of possibilities is long:9,10,11,12,13,14 


Smoking, traumatic injury, (particularly head injuries), viruses and a history of electric shock may contribute to developing ALS. Exposure to environmental toxins such as pesticides and beta-methylamino-l-alanine (found in commercial seafood) may also play a role. So may cyanobacteria, microorganisms that live in desert sands. (This may be related to why U.S. veterans are about twice as likely to develop ALS compared with the general U.S. population). 


Researchers are also looking at immune system abnormalities: mitochondrial dysfunction, oxidative stress and excess glutamate production. All of these are areas of ongoing research.


ALS Research Moves Forward

Because sporadic and familial ALS are so similar, the research into one type can provide fresh insights into what goes wrong in ALS in general.15 So a study focused on ALS at the gene level may provide a blueprint for targeting other ALS-related genes. Likewise, therapies that correct the consequences of a specific gene mutation may lead to treatment for all cases of ALS.16,17 


It will take much more research. That’s what Target ALS hopes to accomplish through its funding efforts. To learn more, visit




2 Amyotrophic Lateral Sclerosis (ALS) Fact Sheet National Institute of Neurological Disorders and Stroke 


4 Vildan, C. et al.: Genetic alterations of C9orf72, SOD1, TARDBP, FUS, and UBQLN2 genes in patients with Amyotrophic Lateral Sclerosis. Cogent Medicine 6 (2019)

5 Mejzini R, et al. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front Neurosci. 2019;13:1310. Published 2019 Dec 6. doi:10.3389/fnins.2019.01310

6 Gibson, S, et al. The evolving genetic risk for sporadic ALS, Neurology Jul 2017, 89 (3) 226-233; DOI: 10.1212/WNL.0000000000004109 (AAN announcement)








14 Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology. 2017 Jul;61:101-130. doi: 10.1016/j.neuro.2016.06.015

15 Gene Therapy

16 Genetics ALS Association

17 “Antisense Oligonucleotides: Can They Take on ALS, SMA, Prions?” | ALZFORUM May 22, 2019




Join Us

Keep up with the latest news, events and ways to get involved.

    Join Us